|1.||Muyembe, Jean-Jacques: 1 article (01/2015)|
|2.||Gillet, Philippe: 1 article (01/2015)|
|3.||Mukadi, Pierre: 1 article (01/2015)|
|4.||Jacobs, Jan: 1 article (01/2015)|
|5.||Barbé, Barbara: 1 article (01/2015)|
|6.||Likwela, Joris: 1 article (01/2015)|
|7.||Luamba, Jean: 1 article (01/2015)|
|8.||Mumba, Dieudonné: 1 article (01/2015)|
|9.||Lukuka, Albert: 1 article (01/2015)|
|10.||Lutumba, Pascal: 1 article (01/2015)|
|2.||Coronary Artery Disease (Coronary Atherosclerosis)
11/01/2007 - "These include: (i) post hoc subgroup analyses of prospective randomized clinical trials of statin therapy among patients with stable coronary artery disease where statins reduce the incidence of new HF; (ii) subgroup analysis of the evidence of statin use in large HF trails with different medication and medical devices; (iii) retrospective observational studies of statin use in HF; and (iv) prospective randomized clinical trials of statins in non-ischemic. "
06/01/1999 - "Therefore, we analysed the data with respect to 4 different groups: (i) asymptomatic left ventricular systolic dysfunction (LVSD)--an early stage leading to chronic HF; (ii) chronic HF; and post-myocardial infarction (MI) LVSD differentiated into (iii) post-MI asymptomatic LVSD and (iv) post-MI chronic HF. "